These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30153181)

  • 21. Strategies to manage the heart failure patient after transplantation.
    Mudge GH
    Clin Cardiol; 1992 Sep; 15 Suppl 1():I37-41. PubMed ID: 1395214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Left-Ventricular Assist Device-Related Complications on Posttransplant Graft Survival.
    Chauhan D; Okoh AK; Fugar S; Karanam R; Baran D; Zucker M; Camacho M; Russo MJ
    Ann Thorac Surg; 2017 Dec; 104(6):1947-1952. PubMed ID: 28935351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mechanical cardiac assistance and artificial heart: historical perspectives].
    Flecher E; Joudinaud T; Grinda JM
    Ann Chir; 2006 Oct; 131(8):473-8. PubMed ID: 16530155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of refractory heart failure with a percutaneous circulatory support device.
    Mammana C; Tespili M; Costalunga A; Jacovoni A; Veritti U; Lorini L; Ferrazzi P; Gavazzi A
    J Cardiovasc Med (Hagerstown); 2006 Jun; 7(6):443-7. PubMed ID: 16721210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current status of cardiac transplantation and left ventricular assist devices.
    Frazier OH
    Tex Heart Inst J; 2010; 37(3):319-21. PubMed ID: 20548811
    [No Abstract]   [Full Text] [Related]  

  • 26. [Heart transplantation--indications and results].
    Loebe M; Hetzer R; Schüler S; Hummel M; Friedel N; Weng Y; Schiessler A
    Zentralbl Chir; 1992; 117(12):681-8. PubMed ID: 1285476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heart transplantation.
    Yun JJ; Gonzalez-Stawinski G
    Minerva Chir; 2009 Feb; 64(1):23-35. PubMed ID: 19202533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Institutional Cost Comparison Between Heart Transplants and Left Ventricular Assist Device Implantations.
    Chimanji N; Kilic A; Hasan A; Higgins RS; Whitson BA; Kilic A
    Exp Clin Transplant; 2016 Dec; 14(6):656-659. PubMed ID: 27063391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost comparison of heart transplant vs. left ventricular assist device therapy at one year.
    Marasco SF; Summerhayes R; Quayle M; McGiffin D; Luthe M
    Clin Transplant; 2016 May; 30(5):598-605. PubMed ID: 26913688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heart transplantation in pediatric age.
    Milanesi O; Cerutti A; Biffanti R; Salvadori S; Gambino A; Stellin G
    J Cardiovasc Med (Hagerstown); 2007 Jan; 8(1):67-71. PubMed ID: 17255820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Pretransplant Continuous-Flow Left Ventricular Assist Devices on Cellular and Antibody-Mediated Rejection and Subsequent Allograft Outcomes.
    Nestorovic EM; Grupper A; Joyce LD; Milic NM; Stulak JM; Edwards BS; Pereira NL; Daly RC; Kushwaha SS
    Am J Cardiol; 2017 Feb; 119(3):452-456. PubMed ID: 27939231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-heart transplantation outcome of HeartMate II-bridged recipients requiring unplanned concomitant temporary right ventricular mechanical support.
    Urban M; Pirk J; Szarszoi O; Besik J; Netuka I
    Interact Cardiovasc Thorac Surg; 2015 Mar; 20(3):372-8. PubMed ID: 25487235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of a pulsatile right ventricular assist device and continuous arteriovenous hemodialysis in a 57-year-old man with a pulsatile left ventricular assist device.
    Chen JM; Levin HR; Catanese KA; Sistino JJ; Landry DW; Rose EA; Oz MC
    J Heart Lung Transplant; 1995; 14(1 Pt 1):186-91. PubMed ID: 7727468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
    Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential Impact of the Proposed Revised UNOS Thoracic Organ Allocation System.
    Rao P; Smith R; Khalpey Z
    Semin Thorac Cardiovasc Surg; 2018; 30(2):129-133. PubMed ID: 29409980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An abdominal left ventricular assist device (ALVAD): perspective and prospects.
    Frazier OH
    Tex Heart Inst J; 2004; 31(3):288. PubMed ID: 15602807
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunosuppression following heart transplantation: prospects and challenges.
    Chang DH; Kittleson MM; Kobashigawa JA
    Immunotherapy; 2014; 6(2):181-94. PubMed ID: 24491091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TNFalpha in patients with end-stage heart failure on medical therapy or supported by a left ventricular assist device.
    Bruggink AH; van Oosterhout MF; De Jonge N; Gmelig-Meyling FH; De Weger RA
    Transpl Immunol; 2008 Apr; 19(1):64-8. PubMed ID: 18346639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The first clinical experience with heart transplantation].
    Shumakov VI; Kazakov EN; Semenovskiĭ ML; Khubutiia ASh; Kormer AIa; Nikolaenko EM; Chestukhin VV; Kolpakov EV; Zimin NK; Dolbin AG
    Grud Serdechnososudistaia Khir; 1990; (5):8-12. PubMed ID: 2203389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Left Ventricular Assist Device Driveline Infections: The Achilles' Heel of Destination Therapy.
    Angud M
    AACN Adv Crit Care; 2015; 26(4):300-5. PubMed ID: 26484989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.